Together Pharma Ltd (TLV:TGTR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 455.00
-9.30 (-2.00%)
Apr 2, 2025, 5:24 PM IDT
Together Pharma Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 8.44 | 3.59 | 5.3 | 5.1 | 5.76 | Upgrade
|
| Cash & Short-Term Investments | 8.44 | 3.59 | 5.3 | 5.1 | 5.76 | Upgrade
|
| Cash Growth | 135.08% | -32.17% | 3.94% | -11.51% | 406.42% | Upgrade
|
| Accounts Receivable | 16.99 | 12.63 | 8.35 | 0.91 | 1.34 | Upgrade
|
| Other Receivables | 2.69 | 0.44 | 0.09 | 0.22 | 0.77 | Upgrade
|
| Receivables | 19.67 | 13.06 | 8.44 | 1.13 | 2.11 | Upgrade
|
| Inventory | 56.38 | 55.26 | 44.59 | 46.53 | 36.8 | Upgrade
|
| Prepaid Expenses | - | 0.37 | 0.99 | 0.41 | 0.3 | Upgrade
|
| Other Current Assets | - | 0.45 | - | 34.08 | 0.47 | Upgrade
|
| Total Current Assets | 84.5 | 72.74 | 59.31 | 87.24 | 45.43 | Upgrade
|
| Property, Plant & Equipment | 35.47 | 35.44 | 36.59 | 34.8 | 35.05 | Upgrade
|
| Long-Term Investments | - | - | 0.1 | - | - | Upgrade
|
| Goodwill | 16.18 | 16.18 | 16.18 | 16.18 | 16.18 | Upgrade
|
| Other Intangible Assets | 8.54 | 12 | 15.43 | 18.43 | 21.91 | Upgrade
|
| Other Long-Term Assets | 2.37 | 2.2 | 2.2 | 2 | 6.66 | Upgrade
|
| Total Assets | 147.05 | 138.55 | 129.79 | 158.65 | 125.23 | Upgrade
|
| Accounts Payable | 21.36 | 13.76 | 9.36 | 6.21 | 7.35 | Upgrade
|
| Accrued Expenses | - | 6.82 | 5.12 | 2.92 | 2.97 | Upgrade
|
| Short-Term Debt | 27.48 | 11.5 | 15.59 | 6.21 | 0.42 | Upgrade
|
| Current Portion of Long-Term Debt | 14 | 5.35 | 6.09 | 39.69 | 4.49 | Upgrade
|
| Current Portion of Leases | 1.48 | 1.56 | 1.4 | 0.62 | 0.02 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.3 | - | Upgrade
|
| Other Current Liabilities | 14.5 | 10.84 | 9.77 | 10.24 | 6.14 | Upgrade
|
| Total Current Liabilities | 78.82 | 49.83 | 47.32 | 66.19 | 21.39 | Upgrade
|
| Long-Term Debt | 9.73 | 25.7 | 25.97 | 29.77 | 43.46 | Upgrade
|
| Long-Term Leases | 10.87 | 10.69 | 11.02 | 9.08 | 8.85 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.45 | 3.99 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 5.97 | 50.88 | 42.45 | 27.86 | 36.77 | Upgrade
|
| Total Liabilities | 108.84 | 141.1 | 126.77 | 132.94 | 110.51 | Upgrade
|
| Common Stock | 239.76 | 194.62 | 197.39 | 183.96 | 152.14 | Upgrade
|
| Retained Earnings | -213.14 | -211.97 | -207.65 | -174.13 | -160.35 | Upgrade
|
| Comprehensive Income & Other | 6.7 | 9.56 | 9.83 | 10.79 | 16.5 | Upgrade
|
| Total Common Equity | 33.32 | -7.79 | -0.43 | 20.63 | 8.29 | Upgrade
|
| Minority Interest | 4.89 | 5.24 | 3.45 | 5.08 | 6.42 | Upgrade
|
| Shareholders' Equity | 38.21 | -2.55 | 3.02 | 25.71 | 14.71 | Upgrade
|
| Total Liabilities & Equity | 147.05 | 138.55 | 129.79 | 158.65 | 125.23 | Upgrade
|
| Total Debt | 63.57 | 54.8 | 60.08 | 85.37 | 57.25 | Upgrade
|
| Net Cash (Debt) | -55.12 | -51.21 | -54.78 | -80.27 | -51.49 | Upgrade
|
| Net Cash Per Share | -4.44 | -5.83 | -6.72 | -11.72 | -8.93 | Upgrade
|
| Filing Date Shares Outstanding | 13.77 | 8.79 | 8.79 | 7.53 | 6.39 | Upgrade
|
| Total Common Shares Outstanding | 13.77 | 8.79 | 8.79 | 7.43 | 5.6 | Upgrade
|
| Working Capital | 5.68 | 22.9 | 11.99 | 21.05 | 24.04 | Upgrade
|
| Book Value Per Share | 2.42 | -0.89 | -0.05 | 2.78 | 1.48 | Upgrade
|
| Tangible Book Value | 8.61 | -35.97 | -32.03 | -13.98 | -29.8 | Upgrade
|
| Tangible Book Value Per Share | 0.63 | -4.09 | -3.65 | -1.88 | -5.33 | Upgrade
|
| Machinery | - | 18.16 | 17.33 | 17 | 15.32 | Upgrade
|
| Leasehold Improvements | - | 14.53 | 14.22 | 13.11 | 13.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.